Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Accumulated Depreciation (2018 - 2025)

Historic Accumulated Depreciation for iBio (IBIO) over the last 8 years, with Q4 2025 value amounting to $1.8 million.

  • iBio's Accumulated Depreciation rose 4038.31% to $1.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.8 million, marking a year-over-year increase of 4038.31%. This contributed to the annual value of $1.5 million for FY2025, which is 4787.34% up from last year.
  • iBio's Accumulated Depreciation amounted to $1.8 million in Q4 2025, which was up 4038.31% from $1.6 million recorded in Q3 2025.
  • iBio's 5-year Accumulated Depreciation high stood at $2.8 million for Q1 2022, and its period low was $115000.0 during Q4 2022.
  • Moreover, its 5-year median value for Accumulated Depreciation was $1.2 million (2021), whereas its average is $1.2 million.
  • In the last 5 years, iBio's Accumulated Depreciation tumbled by 9438.48% in 2022 and then soared by 53391.3% in 2023.
  • Quarter analysis of 5 years shows iBio's Accumulated Depreciation stood at $2.0 million in 2021, then plummeted by 94.38% to $115000.0 in 2022, then surged by 533.91% to $729000.0 in 2023, then soared by 71.88% to $1.3 million in 2024, then surged by 40.38% to $1.8 million in 2025.
  • Its Accumulated Depreciation was $1.8 million in Q4 2025, compared to $1.6 million in Q3 2025 and $1.5 million in Q2 2025.